More Prostate Cancer Patients Choose Surveillance
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
Balancing Early-Stage Prostate Cancer Decisions
Choices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
An Emerging Treatment for Metastatic Prostate Cancer
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
What’s Next? Spring 2021
A new way to evaluate patients with prostate cancer.
by Christina Bennett
When Cancer’s Spread Is Limited
People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
Doing More With Less
Hypofractionation may allow patients to finish radiation treatment sooner.
by Stephen Ornes
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
Robotic Surgery and Cancer
Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.
by Sue Rochman
A Driving Force
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
For Prostate Biopsy, It’s Best to Combine Old and New Methods
Using an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.
by Kate Yandell